New trial results examine whether there's a drug superior to sorafenib when it comes to treating kidney cancer.
African American women are less likely to receive care from leading specialists at Comprehensive Cancer Care centers, but seeking opinions from one can improve outcomes in breast cancer.
Administration of antibiotics prior to immune checkpoint inhibitor therapy may reduce response to treatment and worsen survival outcomes in patients with cancer.
As more younger adults are diagnosed with colorectal cancer, the FDA approved Cologuard, a stool-based, at-home colorectal cancer screening, for adults aged 45 to 49 years.
Investigators assessed effects of TIB on cell number, migration, invasion, estrogen, and progesterone receptor activity and content.
Researchers recently reported on the association between upregulation of EPS8L3 and liver cancer prognosis.
Researchers examined whether cancer or treatment type impacted the symptom burden of survivors of cancer.
The first-of-its-kind collaboration led to the approval of a combination therapy for patients with endometrial cancer.
There's been much research done on how cancer of the reproductive organs affects patients' sexuality; this new study included patients with cancers outside the reproductive organs.
Apalutamide was initially approved in 2018 for patients with non-metastatic castration-resistant prostate cancer; the recent approval is for patients with metastatic castration-sensitive prostate cancer.